Hepatitis C (englisch)

Efficacy and safety of eRVR patients treated with telaprevir, peginterferon alfa-2A and ribavirin: SVR Data from the German non-interventional PAN Study, Christensen et al. . . . vorgestellt anlässlich des Liver Meeting of the American Association for the Study of Liver Diseases 2013 (AASLD) in Washington, DC, (USA).

Zurück